Error: Could not add to watchlist. X

BELLUS Health Inc

+ Watchlist
BLUSF:US
OTC US
0.898
USD
0.042
4.52%
As of 20:10:01 ET on 07/08/2015.
Open
0.900
Day Range
0.895 - 0.916
Volume
16,943
Previous Close
0.940
52Wk Range
0.806 - 1.660
1 Yr Return
-18.41%
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (m USD)
42.565
Shares Outstanding (m)
47.426
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
BELLUS Health Inc. develops drugs for rare diseases, including conditions that affect the kidneys. The Company's main operations are in a Phase III Confirmatory Study for the treatment of AA amyloidosis. BELLUS is also developing treatments for sarcoidosis and hemolytic uremic syndrome.
ADDRESS
275 Armand-Frappier Boulevard
Laval, QC H7V 4A7
Canada
PHONE
1-450-680-4500
  • Roberto Bellini
    President/CEO
  • Denis Garceau
    Senior VP:Drug Development
  • Francois Desjardins
    VP:Finance
  • Tony Matzouranis
    VP:Business Development
Show More